APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sequencing and Spatial Omics Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sequencing and Spatial Omics Platform Market Outlook and Growth Opportunities 2026

5 June 2026205 pages

Choose your research edition.

Industry ResearchSequencing and Spatial Omics Platform Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Sequencing and Spatial Omics Platform Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Sequencing and Spatial Omics Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sequencing and Spatial Omics Platform Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Sequencing and Spatial Omics Platform Market Analysis and Forecast 2026-2032254 pages · $4,950 USD

Market perspective

The global Sequencing and Spatial Omics Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sequencing and Spatial Omics Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sequencing and Spatial Omics Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sequencing and Spatial Omics Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sequencing and Spatial Omics Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sequencing and Spatial Omics Platform market include Illumina, Thermo Fisher Scientific, PacBio, 10x Genomics, Element Biosciences, Ultima Genomics, Bruker Spatial Biology, Vizgen and Quanterix, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Sequencing and Spatial Omics Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sequencing and Spatial Omics Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sequencing and Spatial Omics Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Sequencing and Spatial Omics Platform market.

Sequencing and Spatial Omics Platform Segment by Company

Illumina

Thermo Fisher Scientific

PacBio

10x Genomics

Element Biosciences

Ultima Genomics

Bruker Spatial Biology

Vizgen

Quanterix

Standard BioTools

Oxford Nanopore Technologies

QIAGEN

Miltenyi Biotec

MGI Tech

STOmics

Novogene

Biomarker Technologies

SeekGene

Takara Bio

Rhelixa

Sequencing and Spatial Omics Platform Segment by Type

Single-Omics Platform

Multi-Omics Integration Platform

Others

Sequencing and Spatial Omics Platform Segment by Application

Biomedicine

Clinical Diagnosis

Agriculture and Animal and Plant Breeding

Others

Sequencing and Spatial Omics Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sequencing and Spatial Omics Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Sequencing and Spatial Omics Platform key companies, revenue, market share, and recent developments.

3. To split the Sequencing and Spatial Omics Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Sequencing and Spatial Omics Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sequencing and Spatial Omics Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Sequencing and Spatial Omics Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sequencing and Spatial Omics Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sequencing and Spatial Omics Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sequencing and Spatial Omics Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sequencing and Spatial Omics Platform industry.

Chapter 3: Detailed analysis of Sequencing and Spatial Omics Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Sequencing and Spatial Omics Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Sequencing and Spatial Omics Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sequencing and Spatial Omics Platform Industry Trends Table 2. Sequencing and Spatial Omics Platform Industry Drivers Table 3. Sequencing and Spatial Omics Platform Industry Opportunities and Challenges Table 4. Sequencing and Spatial Omics Platform Industry Restraints Table 5. Global Sequencing and Spatial Omics Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sequencing and Spatial Omics Platform Revenue Share by Company (2021-2026) Table 7. Global Sequencing and Spatial Omics Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Sequencing and Spatial Omics Platform Key Company Manufacturing Base & Headquarters Table 9. Global Sequencing and Spatial Omics Platform Company, Product Type & Application Table 10. Global Sequencing and Spatial Omics Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Sequencing and Spatial Omics Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single-Omics Platform Table 15. Significant Companies of Multi-Omics Integration Platform Table 16. Significant Companies of Others Table 17. Global Sequencing and Spatial Omics Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Sequencing and Spatial Omics Platform Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Sequencing and Spatial Omics Platform Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Sequencing and Spatial Omics Platform Sales Value Share by Type (2021-2026) Table 21. Global Sequencing and Spatial Omics Platform Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biomedicine Table 23. Significant Companies of Clinical Diagnosis Table 24. Significant Companies of Agriculture and Animal and Plant Breeding Table 25. Significant Companies of Others Table 26. Global Sequencing and Spatial Omics Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Sequencing and Spatial Omics Platform Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Sequencing and Spatial Omics Platform Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Sequencing and Spatial Omics Platform Sales Value Share by Application (2021-2026) Table 30. Global Sequencing and Spatial Omics Platform Sales Value Share by Application (2027-2032) Table 31. Global Sequencing and Spatial Omics Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Sequencing and Spatial Omics Platform Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Sequencing and Spatial Omics Platform Sales Value Share by Region (2021-2026) Table 34. Global Sequencing and Spatial Omics Platform Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Sequencing and Spatial Omics Platform Sales Value Share by Region (2027-2032) Table 36. Global Sequencing and Spatial Omics Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Sequencing and Spatial Omics Platform Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Sequencing and Spatial Omics Platform Sales Value Market Share by Country (2021-2026) Table 39. Global Sequencing and Spatial Omics Platform Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Sequencing and Spatial Omics Platform Sales Value Market Share by Country (2027-2032) Table 41. Illumina Company Information Table 42. Illumina Business Overview Table 43. Illumina Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Illumina Sequencing and Spatial Omics Platform Product Portfolio Table 45. Illumina Recent Development Table 46. Thermo Fisher Scientific Company Information Table 47. Thermo Fisher Scientific Business Overview Table 48. Thermo Fisher Scientific Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Thermo Fisher Scientific Sequencing and Spatial Omics Platform Product Portfolio Table 50. Thermo Fisher Scientific Recent Development Table 51. PacBio Company Information Table 52. PacBio Business Overview Table 53. PacBio Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. PacBio Sequencing and Spatial Omics Platform Product Portfolio Table 55. PacBio Recent Development Table 56. 10x Genomics Company Information Table 57. 10x Genomics Business Overview Table 58. 10x Genomics Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. 10x Genomics Sequencing and Spatial Omics Platform Product Portfolio Table 60. 10x Genomics Recent Development Table 61. Element Biosciences Company Information Table 62. Element Biosciences Business Overview Table 63. Element Biosciences Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Element Biosciences Sequencing and Spatial Omics Platform Product Portfolio Table 65. Element Biosciences Recent Development Table 66. Ultima Genomics Company Information Table 67. Ultima Genomics Business Overview Table 68. Ultima Genomics Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Ultima Genomics Sequencing and Spatial Omics Platform Product Portfolio Table 70. Ultima Genomics Recent Development Table 71. Bruker Spatial Biology Company Information Table 72. Bruker Spatial Biology Business Overview Table 73. Bruker Spatial Biology Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bruker Spatial Biology Sequencing and Spatial Omics Platform Product Portfolio Table 75. Bruker Spatial Biology Recent Development Table 76. Vizgen Company Information Table 77. Vizgen Business Overview Table 78. Vizgen Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Vizgen Sequencing and Spatial Omics Platform Product Portfolio Table 80. Vizgen Recent Development Table 81. Quanterix Company Information Table 82. Quanterix Business Overview Table 83. Quanterix Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Quanterix Sequencing and Spatial Omics Platform Product Portfolio Table 85. Quanterix Recent Development Table 86. Standard BioTools Company Information Table 87. Standard BioTools Business Overview Table 88. Standard BioTools Sequencing and Spatial Omics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Standard BioTools Sequencing and Spatial Omics Platform Product Portfolio Table 90. Standard BioTools Recent Development Table 91. Oxford Nanopore Technologies Company Information Table 92. Oxford Nanopore Technologies Business Overview Table 93. Oxford Nanopore Technologies Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Oxford Nanopore Technologies Sequencing and Spatial Omics Platform Product Portfolio Table 95. Oxford Nanopore Technologies Recent Development Table 96. QIAGEN Company Information Table 97. QIAGEN Business Overview Table 98. QIAGEN Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. QIAGEN Sequencing and Spatial Omics Platform Product Portfolio Table 100. QIAGEN Recent Development Table 101. Miltenyi Biotec Company Information Table 102. Miltenyi Biotec Business Overview Table 103. Miltenyi Biotec Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Miltenyi Biotec Sequencing and Spatial Omics Platform Product Portfolio Table 105. Miltenyi Biotec Recent Development Table 106. MGI Tech Company Information Table 107. MGI Tech Business Overview Table 108. MGI Tech Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. MGI Tech Sequencing and Spatial Omics Platform Product Portfolio Table 110. MGI Tech Recent Development Table 111. STOmics Company Information Table 112. STOmics Business Overview Table 113. STOmics Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. STOmics Sequencing and Spatial Omics Platform Product Portfolio Table 115. STOmics Recent Development Table 116. Novogene Company Information Table 117. Novogene Business Overview Table 118. Novogene Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Novogene Sequencing and Spatial Omics Platform Product Portfolio Table 120. Novogene Recent Development Table 121. Biomarker Technologies Company Information Table 122. Biomarker Technologies Business Overview Table 123. Biomarker Technologies Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Biomarker Technologies Sequencing and Spatial Omics Platform Product Portfolio Table 125. Biomarker Technologies Recent Development Table 126. SeekGene Company Information Table 127. SeekGene Business Overview Table 128. SeekGene Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. SeekGene Sequencing and Spatial Omics Platform Product Portfolio Table 130. SeekGene Recent Development Table 131. Takara Bio Company Information Table 132. Takara Bio Business Overview Table 133. Takara Bio Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Takara Bio Sequencing and Spatial Omics Platform Product Portfolio Table 135. Takara Bio Recent Development Table 136. Rhelixa Company Information Table 137. Rhelixa Business Overview Table 138. Rhelixa Sequencing and Spatial Omics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Rhelixa Sequencing and Spatial Omics Platform Product Portfolio Table 140. Rhelixa Recent Development Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Sequencing and Spatial Omics Platform Product Image Figure 2. Global Sequencing and Spatial Omics Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sequencing and Spatial Omics Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Sequencing and Spatial Omics Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single-Omics Platform Image Figure 8. Multi-Omics Integration Platform Image Figure 9. Others Image Figure 10. Global Sequencing and Spatial Omics Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Sequencing and Spatial Omics Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Sequencing and Spatial Omics Platform Sales Value Share by Type (2021-2032) Figure 13. Biomedicine Image Figure 14. Clinical Diagnosis Image Figure 15. Agriculture and Animal and Plant Breeding Image Figure 16. Others Image Figure 17. Global Sequencing and Spatial Omics Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Sequencing and Spatial Omics Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Sequencing and Spatial Omics Platform Sales Value Share by Application (2021-2032) Figure 20. Global Sequencing and Spatial Omics Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Sequencing and Spatial Omics Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Sequencing and Spatial Omics Platform Sales Value (2021-2032) & (US$ Million) Figure 23. North America Sequencing and Spatial Omics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Sequencing and Spatial Omics Platform Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Sequencing and Spatial Omics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Sequencing and Spatial Omics Platform Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Sequencing and Spatial Omics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Sequencing and Spatial Omics Platform Sales Value (2021-2032) & (US$ Million) Figure 29. South America Sequencing and Spatial Omics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Sequencing and Spatial Omics Platform Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Sequencing and Spatial Omics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Omics Platform
  • Multi-Omics Integration Platform
  • Others
Applications
  • Biomedicine
  • Clinical Diagnosis
  • Agriculture and Animal and Plant Breeding
  • Others
Companies covered
  • Illumina
  • Thermo Fisher Scientific
  • PacBio
  • 10x Genomics
  • Element Biosciences
  • Ultima Genomics
  • Bruker Spatial Biology
  • Vizgen
  • Quanterix
  • Standard BioTools
  • Oxford Nanopore Technologies
  • QIAGEN
  • Miltenyi Biotec
  • MGI Tech
  • STOmics
  • Novogene
  • Biomarker Technologies
  • SeekGene
  • Takara Bio
  • Rhelixa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sequencing and Spatial Omics Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sequencing and Spatial Omics Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Sequencing and Spatial Omics Platform Market Dynamics
  1. 2.1 Sequencing and Spatial Omics Platform Industry Trends
  2. 2.2 Sequencing and Spatial Omics Platform Industry Drivers
  3. 2.3 Sequencing and Spatial Omics Platform Industry Opportunities and Challenges
  4. 2.4 Sequencing and Spatial Omics Platform Industry Restraints
3 Sequencing and Spatial Omics Platform Market by Company
  1. 3.1 Global Sequencing and Spatial Omics Platform Company Revenue Ranking in 2025
  2. 3.2 Global Sequencing and Spatial Omics Platform Revenue by Company (2021-2026)
  3. 3.3 Global Sequencing and Spatial Omics Platform Company Ranking (2024-2026)
  4. 3.4 Global Sequencing and Spatial Omics Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Sequencing and Spatial Omics Platform Company Product Type and Application
  6. 3.6 Global Sequencing and Spatial Omics Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Sequencing and Spatial Omics Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Sequencing and Spatial Omics Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Sequencing and Spatial Omics Platform Market by Type
  1. 4.1 Sequencing and Spatial Omics Platform Type Introduction
  2. 4.1.1 Single-Omics Platform
  3. 4.1.2 Multi-Omics Integration Platform
  4. 4.1.3 Others
  5. 4.2 Global Sequencing and Spatial Omics Platform Sales Value by Type
  6. 4.2.1 Global Sequencing and Spatial Omics Platform Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sequencing and Spatial Omics Platform Sales Value by Type (2021-2032)
  8. 4.2.3 Global Sequencing and Spatial Omics Platform Sales Value Share by Type (2021-2032)
5 Sequencing and Spatial Omics Platform Market by Application
  1. 5.1 Sequencing and Spatial Omics Platform Application Introduction
  2. 5.1.1 Biomedicine
  3. 5.1.2 Clinical Diagnosis
  4. 5.1.3 Agriculture and Animal and Plant Breeding
  5. 5.1.4 Others
  6. 5.2 Global Sequencing and Spatial Omics Platform Sales Value by Application
  7. 5.2.1 Global Sequencing and Spatial Omics Platform Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Sequencing and Spatial Omics Platform Sales Value by Application (2021-2032)
  9. 5.2.3 Global Sequencing and Spatial Omics Platform Sales Value Share by Application (2021-2032)
6 Sequencing and Spatial Omics Platform Regional Value Analysis
  1. 6.1 Global Sequencing and Spatial Omics Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sequencing and Spatial Omics Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Sequencing and Spatial Omics Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Sequencing and Spatial Omics Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sequencing and Spatial Omics Platform Sales Value (2021-2032)
  7. 6.3.2 North America Sequencing and Spatial Omics Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Sequencing and Spatial Omics Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Sequencing and Spatial Omics Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Sequencing and Spatial Omics Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Sequencing and Spatial Omics Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Sequencing and Spatial Omics Platform Sales Value (2021-2032)
  16. 6.6.2 South America Sequencing and Spatial Omics Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Sequencing and Spatial Omics Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Sequencing and Spatial Omics Platform Sales Value Share by Country, 2025 VS 2032
7 Sequencing and Spatial Omics Platform Country-level Value Analysis
  1. 7.1 Global Sequencing and Spatial Omics Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sequencing and Spatial Omics Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Sequencing and Spatial Omics Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Sequencing and Spatial Omics Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Sequencing and Spatial Omics Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Sequencing and Spatial Omics Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Sequencing and Spatial Omics Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina
  2. 8.1.1 Illumina Company Information
  3. 8.1.2 Illumina Business Overview
  4. 8.1.3 Illumina Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina Sequencing and Spatial Omics Platform Product Portfolio
  6. 8.1.5 Illumina Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Sequencing and Spatial Omics Platform Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 PacBio
  14. 8.3.1 PacBio Company Information
  15. 8.3.2 PacBio Business Overview
  16. 8.3.3 PacBio Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PacBio Sequencing and Spatial Omics Platform Product Portfolio
  18. 8.3.5 PacBio Recent Developments
  19. 8.4 10x Genomics
  20. 8.4.1 10x Genomics Company Information
  21. 8.4.2 10x Genomics Business Overview
  22. 8.4.3 10x Genomics Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 10x Genomics Sequencing and Spatial Omics Platform Product Portfolio
  24. 8.4.5 10x Genomics Recent Developments
  25. 8.5 Element Biosciences
  26. 8.5.1 Element Biosciences Company Information
  27. 8.5.2 Element Biosciences Business Overview
  28. 8.5.3 Element Biosciences Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Element Biosciences Sequencing and Spatial Omics Platform Product Portfolio
  30. 8.5.5 Element Biosciences Recent Developments
  31. 8.6 Ultima Genomics
  32. 8.6.1 Ultima Genomics Company Information
  33. 8.6.2 Ultima Genomics Business Overview
  34. 8.6.3 Ultima Genomics Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ultima Genomics Sequencing and Spatial Omics Platform Product Portfolio
  36. 8.6.5 Ultima Genomics Recent Developments
  37. 8.7 Bruker Spatial Biology
  38. 8.7.1 Bruker Spatial Biology Company Information
  39. 8.7.2 Bruker Spatial Biology Business Overview
  40. 8.7.3 Bruker Spatial Biology Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bruker Spatial Biology Sequencing and Spatial Omics Platform Product Portfolio
  42. 8.7.5 Bruker Spatial Biology Recent Developments
  43. 8.8 Vizgen
  44. 8.8.1 Vizgen Company Information
  45. 8.8.2 Vizgen Business Overview
  46. 8.8.3 Vizgen Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vizgen Sequencing and Spatial Omics Platform Product Portfolio
  48. 8.8.5 Vizgen Recent Developments
  49. 8.9 Quanterix
  50. 8.9.1 Quanterix Company Information
  51. 8.9.2 Quanterix Business Overview
  52. 8.9.3 Quanterix Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Quanterix Sequencing and Spatial Omics Platform Product Portfolio
  54. 8.9.5 Quanterix Recent Developments
  55. 8.10 Standard BioTools
  56. 8.10.1 Standard BioTools Company Information
  57. 8.10.2 Standard BioTools Business Overview
  58. 8.10.3 Standard BioTools Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Standard BioTools Sequencing and Spatial Omics Platform Product Portfolio
  60. 8.10.5 Standard BioTools Recent Developments
  61. 8.11 Oxford Nanopore Technologies
  62. 8.11.1 Oxford Nanopore Technologies Company Information
  63. 8.11.2 Oxford Nanopore Technologies Business Overview
  64. 8.11.3 Oxford Nanopore Technologies Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Oxford Nanopore Technologies Sequencing and Spatial Omics Platform Product Portfolio
  66. 8.11.5 Oxford Nanopore Technologies Recent Developments
  67. 8.12 QIAGEN
  68. 8.12.1 QIAGEN Company Information
  69. 8.12.2 QIAGEN Business Overview
  70. 8.12.3 QIAGEN Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 QIAGEN Sequencing and Spatial Omics Platform Product Portfolio
  72. 8.12.5 QIAGEN Recent Developments
  73. 8.13 Miltenyi Biotec
  74. 8.13.1 Miltenyi Biotec Company Information
  75. 8.13.2 Miltenyi Biotec Business Overview
  76. 8.13.3 Miltenyi Biotec Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Miltenyi Biotec Sequencing and Spatial Omics Platform Product Portfolio
  78. 8.13.5 Miltenyi Biotec Recent Developments
  79. 8.14 MGI Tech
  80. 8.14.1 MGI Tech Company Information
  81. 8.14.2 MGI Tech Business Overview
  82. 8.14.3 MGI Tech Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MGI Tech Sequencing and Spatial Omics Platform Product Portfolio
  84. 8.14.5 MGI Tech Recent Developments
  85. 8.15 STOmics
  86. 8.15.1 STOmics Company Information
  87. 8.15.2 STOmics Business Overview
  88. 8.15.3 STOmics Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 STOmics Sequencing and Spatial Omics Platform Product Portfolio
  90. 8.15.5 STOmics Recent Developments
  91. 8.16 Novogene
  92. 8.16.1 Novogene Company Information
  93. 8.16.2 Novogene Business Overview
  94. 8.16.3 Novogene Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Novogene Sequencing and Spatial Omics Platform Product Portfolio
  96. 8.16.5 Novogene Recent Developments
  97. 8.17 Biomarker Technologies
  98. 8.17.1 Biomarker Technologies Company Information
  99. 8.17.2 Biomarker Technologies Business Overview
  100. 8.17.3 Biomarker Technologies Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biomarker Technologies Sequencing and Spatial Omics Platform Product Portfolio
  102. 8.17.5 Biomarker Technologies Recent Developments
  103. 8.18 SeekGene
  104. 8.18.1 SeekGene Company Information
  105. 8.18.2 SeekGene Business Overview
  106. 8.18.3 SeekGene Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  107. 8.18.4 SeekGene Sequencing and Spatial Omics Platform Product Portfolio
  108. 8.18.5 SeekGene Recent Developments
  109. 8.19 Takara Bio
  110. 8.19.1 Takara Bio Company Information
  111. 8.19.2 Takara Bio Business Overview
  112. 8.19.3 Takara Bio Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Takara Bio Sequencing and Spatial Omics Platform Product Portfolio
  114. 8.19.5 Takara Bio Recent Developments
  115. 8.20 Rhelixa
  116. 8.20.1 Rhelixa Company Information
  117. 8.20.2 Rhelixa Business Overview
  118. 8.20.3 Rhelixa Sequencing and Spatial Omics Platform Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Rhelixa Sequencing and Spatial Omics Platform Product Portfolio
  120. 8.20.5 Rhelixa Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst